Any 0 3 0 3 O
chronic 4 11 4 11 B-chronic_disease
disorder 12 20 12 20 I-chronic_disease
or 21 23 21 23 O
severe 24 30 24 30 B-chronic_disease
disease 31 38 31 38 I-chronic_disease
which 39 44 39 44 O
, 44 45 44 45 O
in 46 48 46 48 O
the 49 52 49 52 O
opinion 53 60 53 60 O
of 61 63 61 63 O
the 64 67 64 67 O
Investigator 68 80 68 80 O
, 80 81 80 81 O
might 82 87 82 87 O
jeopardise 88 98 88 98 O
the 99 102 99 102 O
patient 103 110 103 110 O
's 110 112 110 112 O
safety 113 119 113 119 O
or 120 122 120 122 O
compliance 123 133 123 133 O
with 134 138 134 138 O
the 139 142 139 142 O
protocol 143 151 143 151 O

Any 0 3 152 155 O
history 4 11 156 163 O
of 12 14 164 166 O
FIX 15 18 167 170 B-treatment
inhibitors 19 29 171 181 I-treatment
( 30 31 182 183 O
defined 31 38 183 190 O
by 39 41 191 193 O
medical 42 49 194 201 O
records 50 57 202 209 O
) 57 58 209 210 O

Congenital 0 10 211 221 B-chronic_disease
or 11 13 222 224 I-chronic_disease
acquired 14 22 225 233 I-chronic_disease
coagulation 23 34 234 245 I-chronic_disease
disorder 35 43 246 254 I-chronic_disease
other 44 49 255 260 O
than 50 54 261 265 O
haemophilia 55 66 266 277 B-chronic_disease
B 67 68 278 279 I-chronic_disease

Known 0 5 280 285 O
or 6 8 286 288 O
suspected 9 18 289 298 O
hypersensitivity 19 35 299 315 O
to 36 38 316 318 O
trial 39 44 319 324 B-allergy_name
product 45 52 325 332 I-allergy_name
or 53 55 333 335 I-allergy_name
related 56 63 336 343 I-allergy_name
products 64 72 344 352 I-allergy_name

Male 0 4 353 357 B-gender

Patients 0 8 358 366 O
with 9 13 367 371 O
the 14 17 372 375 O
diagnosis 18 27 376 385 O
of 28 30 386 388 O
haemophilia 31 42 389 400 B-chronic_disease
B 43 44 401 402 I-chronic_disease
( 45 46 403 404 B-clinical_variable
FIX 46 49 404 407 I-clinical_variable
( 50 51 408 409 I-clinical_variable
coagulation 51 62 409 420 I-clinical_variable
factor 63 69 421 427 I-clinical_variable
IX 70 72 428 430 I-clinical_variable
) 72 73 430 431 I-clinical_variable
activity 74 82 432 440 I-clinical_variable
level 83 88 441 446 I-clinical_variable
below 89 94 447 452 O
or 95 97 453 455 O
equal 98 103 456 461 O
to 104 106 462 464 O
2 107 108 465 466 B-upper_bound
% 108 109 466 467 I-upper_bound
) 109 110 467 468 O
based 111 116 469 474 O
on 117 119 475 477 O
medical 120 127 478 485 O
records 128 135 486 493 O
or 136 138 494 496 O
central 139 146 497 504 O
laboratory 147 157 505 515 O
results 158 165 516 523 O

Previously 0 10 524 534 O
untreated 11 20 535 544 O
or 21 23 545 547 O
exposed 24 31 548 555 O
to 32 34 556 558 O
FIX 35 38 559 562 B-treatment
containing 39 49 563 573 I-treatment
products 50 58 574 582 I-treatment
less 59 63 583 587 O
than 64 68 588 592 O
or 69 71 593 595 O
equal 72 77 596 601 O
to 78 80 602 604 O
3 81 82 605 606 B-upper_bound
exposure 83 91 607 615 O
days 92 96 616 620 O
( 97 98 621 622 O
5 98 99 622 623 O
previous 100 108 624 632 O
exposures 109 118 633 642 O
to 119 121 643 645 O
blood 122 127 646 651 O
components 128 138 652 662 O
is 139 141 663 665 O
acceptable 142 152 666 676 O
) 152 153 676 677 O

Receipt 0 7 678 685 O
of 8 10 686 688 O
any 11 14 689 692 O
investigational 15 30 693 708 O
medicinal 31 40 709 718 O
product 41 48 719 726 O
within 49 55 727 733 O
30 56 58 734 736 B-upper_bound
days 59 63 737 741 I-upper_bound
before 64 70 742 748 O
screening 71 80 749 758 O

age 0 3 759 762 B-age
below 4 9 763 768 O
6 10 11 769 770 B-upper_bound
years 12 17 771 776 I-upper_bound
at 18 20 777 779 O
the 21 24 780 783 O
time 25 29 784 788 O
of 30 32 789 791 O
signing 33 40 792 799 O
informed 41 49 800 808 O
consent 50 57 809 816 O

